Pediatrics · Poplar Bluff, MO
NPI
1740268333
Since 2006
Specialty
Pediatrics
Code 208000000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
225 Physicians Park Ste 304
Poplar Bluff, MO, 63901
Phone (573) 727-5500
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,213
101 services
Medicare patients, 2023
21
Average age 59
Drug cost, 2024
$1.4M
6,110 prescriptions
Company payments, 2025
$793
From 12 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Shaun A Ross was code 80053 (clinical chemistry), 20 times for 18 patients. In total Shaun A Ross billed 101 services in 17 codes, and Medicare paid $1,213.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80053 Clinical Chemistry | Office | 20 | 18 | $10.35 | $207 |
| 80061 Clinical Chemistry | Office | 12 | 12 | $13.12 | $157 |
| 84443 Clinical Chemistry | Office | 12 | 11 | $16.46 | $198 |
| 83036 Blood Count | Office | 11 | 11 | $9.52 | $105 |
By year: 2022 $1,713 for 154 services; 2023 $1,213 for 101 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 20 | 18 | $10.35 | $207 |
| 80061 Clinical Chemistry | 12 | 12 | $13.12 | $157 |
| 84443 Clinical Chemistry | 12 | 11 | $16.46 | $198 |
| 83036 Blood Count | 11 | 11 | $9.52 | $105 |
Medicare prescription drug claims, 2024
In 2024, the drug Shaun A Ross prescribed most often to Medicare patients was Levothyroxine Sodium, with 622 prescriptions and refills. In total Shaun A Ross wrote 6,110 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 622 | 928 | 119 | $3,551 |
| Ozempic Semaglutide | 307 | 355 | 53 | $334K |
| Lisinopril Generic | 263 | 439 | 58 | $1,150 |
| Glimepiride Generic | 218 | 360 | 50 | $1,038 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 217 | 338 | 51 | $37K |
| Pioglitazone Hcl Generic | 190 | 303 | 42 | $1,440 |
| Jardiance Empagliflozin | 177 | 216 | 35 | $127K |
| Metformin Hcl Generic | 168 | 321 | 40 | $813 |
| Gabapentin Generic | 148 | 199 | 29 | $2,240 |
| Simvastatin Generic | 146 | 246 | 30 | $561 |
| Atorvastatin Calcium Generic | 132 | 268 | 33 | $1,015 |
| Metformin Hcl Er Metformin Hcl | 122 | 251 | 31 | $527 |
| Methimazole Generic | 121 | 169 | 24 | $706 |
| Mounjaro Tirzepatide | 112 | 123 | 17 | $127K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 110 | 133 | 34 | $37K |
Brand drugs: 2,028 claims; generic drugs: 3,645 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shaun A Ross $793 ($793 in general payments such as food, travel and fees) from 12 companies. The largest payer was Neurocrine BioSciences, Inc. with $221.
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. NBIX | 9 | $221 |
| Lilly USA, LLC LLY | 7 | $164 |
| Dexcom, Inc. DXCM | 4 | $76.75 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $57.05 |
| Novo Nordisk Inc NVO | 3 | $50.92 |
| Insulet Corporation PODD | 3 | $44.03 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.48 |
| Abbott Laboratories ABT | 2 | $39.36 |
| Tandem Diabetes Care, Inc. TNDM | 3 | $34.53 |
| Abbvie Inc. ABBV | 1 | $25.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.